European Heart Journal Lopes, L R, Garcia-Hernández, S, Lorenzini, M, Futema, M, Chumakova, O, Zateyshchikov, D, Isidoro-Garcia, M, Villacorta, E, Escobar-Lopez, L, Garcia-Pavia, P, Bilbao, R, Dobarro, D, Sandin-Fuentes, M, Catalli, C, Gener Querol, B, Mezcua, A, Garcia Pinilla, J, Bloch Rasmussen, T, Ferreira-Aguar, A, Revilla-Martí, P, Basurte Elorz, M T, Bautista Paves, A, Ramon Gimeno, J, Figueroa, A V, Franco-Gutierrez, R, Fuentes-Cañamero, M E, Martinez Moreno, M, Ortiz-Genga, M, Piqueras-Flores, J, Analia Ramos, K, Rudzitis, A, Ruiz-Guerrero, L, Stein, R, Triguero-Bocharán, M, De La Higuera, L, Ochoa, J P, Abu-Bonsrah, D, Kwok, C Y T, Smith, J B, Porrello, E R, Akhtar, M M, Jager, J, Ashworth, M, Syrris, P, Elliott, D A, Monserrat, L & Elliott, P M 2021, ' Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy ', European Heart Journal, vol. 42, no. 32, pp. 3063-3073 . https://doi.org/10.1093/eurheartj/ehab424 DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria instname EUROPEAN HEART JOURNAL r-FISABIO. Repositorio Institucional de Producción Científica
The Lancet The Lancet, Elsevier, 2018, 391 (10117), pp.219-229. ⟨10.1016/S0140-6736(17)32409-1⟩ Anand, S S, Bosch, J, Eikelboom, J W, Connolly, S J, Diaz, R, Widimsky, P, Aboyans, V, Alings, M, Kakkar, A K, Keltai, K, Maggioni, A P, Lewis, B S, Störk, S, Zhu, J, Lopez-Jaramillo, P, O'Donnell, M, Commerford, P J, Vinereanu, D, Pogosova, N, Ryden, L, Fox, K A A, Bhatt, D L, Misselwitz, F, Varigos, J D, Vanassche, T, Avezum, A A, Chen, E, Branch, K, Leong, D P, Bangdiwala, S I, Hart, R G, Yusuf, S & COMPASS Investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 219-229 . https://doi.org/10.1016/S0140-6736(17)32409-1 Anand, S S, Bosch, J, Eikelboom, J W, Connolly, S J, Diaz, R, Widimsky, P, Aboyans, V, Alings, M, Kakkar, A K, Keltai, K, Maggioni, A P, Lewis, B S, Störk, S, Zhu, J, Lopez-Jaramillo, P, O'Donnell, M, Commerford, P J, Vinereanu, D, Pogosova, N, Ryden, L, Fox, K A A, Bhatt, D L, Misselwitz, F, Varigos, J D, Vanassche, T, Avezum, A A, Chen, E, Branch, K, Leong, D P, Bangdiwala, S I, Hart, R G, Yusuf, S, COMPASS Investigators & Houlind, K C 2018, ' Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 219-229 . https://doi.org/10.1016/S0140-6736(17)32409-1